Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience JOURNAL OF HEART AND LUNG TRANSPLANTATION Shiba, N., Chan, M. C., Kwok, B. W., Valantine, H. A., Robbins, R. C., Hunt, S. A. 2004; 23 (2): 155-164

Abstract

Truly long term survival post heart transplantation has become increasingly frequent over the past two decades.We analyzed multiple clinical outcomes in the cohort of 140 patients in the Stanford database who underwent heart transplantation after the introduction of cyclosporine-based immunosuppression in 1980 and survived >10 years after transplantation.We found generally excellent functional status in these patients, but a high incidence of hypertension, renal dysfunction, and graft CAD as well as malignancy.With continued improvement in post-transplant survival rates, providing complex care for such long-term recipients as these will assume increasing clinical importance in the everyday practice of transplant medicine and these data highlight the problems to be anticipated.

View details for DOI 10.1016/S1053-2498(03)00147-5

View details for Web of Science ID 000188759100001

View details for PubMedID 14761762